MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Ownership - Who owns Neurogene?
Profile
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
513.77M
P/E Ratio
N/A
Total Cash
111.03M
Projected Growth
N/A
Total Debt
15.89M
Revenue
925K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.55
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
Fundamentals
NGNE
Capitalization
514M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
111M
Total Cash/Share
8.55
Total Debt
15.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
925K
ROE
N/A
Book Value
155M
P/B Ratio
3.31
Cash Flow
N/A
Earnings
-3.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
12.17
Current Revenue Per Employee
10164.83
Dividends Per Share - Security
N/A
EBITDA
-44.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.85
Shares Held By Institutions
772M
Shares Outstanding - Current
13M
Total Liabilities
24.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
106.398
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com